Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Agreement Between R2 and R2* Liver Iron Estimates Is Independent of the Type of Iron Removal Therapy: Results from the Twitch Trial

John C Wood, MD PhD, Tim St Pierre, PhD, Banu Aygun, MD, Nicole Mortier, PA-C, William H Schultz, MHS PA, Connie M. Piccone, MD, Jane Hankins, MD MS, Zora R. Rogers, MD, William Owen, MD, Isaac Odame, MBChB, FRCPath, FRCPC, Sharada A. Sarnaik, MD, Lee Hilliard, MD, Alan R. Cohen, MD, Russell E. Ware, MD PhD

Blood (2016) 128 (22): 1274.

https://doi.org/10.1182/blood.V128.22.1274.1274

Published: 2016

Journal Articles

Hydroxyurea at Maximal Tolerated Dose (MTD) Prior to Completion of the β-Globin Switch Has Additive but Not Sustained Benefits in Fetal Hemoglobin Production

Christina Abrams, MD, Joseph Moen, MS, Guolian Kang, PhD, Winfred C. Wang, MD, Jane Hankins, MD MS, Jeremie H. Estepp, MD

Blood (2016) 128 (22): 125.

https://doi.org/10.1182/blood.V128.22.125.125

Published: 2016

Journal Articles

Genetic Predictors of Hydroxyurea Response in Children with Sickle Cell Disease.

Jenny McDade, DO, MS, Jonathan M Flanagan, PhD, Nicole Mortier, MHS, PA-C, Matthew Smeltzer, MS, Thad A Howard, MS, Amy Cone, FNP, Jane Hankins, MD, MS, Banu Aygun, MD, Song Wu, PhD, Russell E Ware, MD, PhD

Blood (2009) 114 (22): 820.

https://doi.org/10.1182/blood.V114.22.820.820

Published: 2009

Journal Articles

Cardiac T2* Magnetic Resonance Imaging (MRI) in Iron Overload and Ventricular Diastolic Function.

Jane Hankins, MD, MS, Claudia Hillenbrand, PhD, Vijay Joshi, MD, Ralf Loeffler, PhD, Ruitian Song, PhD, Russell Ware, MD, PhD, Eileen Hansbury, PA-C, Martha Rieman, FNP, Nicole Mortier, MHS, PA-C, Matt Smeltzer, MS, Chin-Shang Li, PhD, M. Beth McCarville, MD

Blood (2007) 110 (11): 2676.

https://doi.org/10.1182/blood.V110.11.2676.2676

Published: 2007

Journal Articles

Phase I Study of Combination Treatment with Hydroxyurea and Magnesium Pidolate in Children with Sickle Cell Anemia.

Jane Hankins, MD, MS, Lynn Wynn, MSN, PNP, Carlo Brugnara, PhD, Cheryl Hillery, MD, Chin-Shang Li, PhD, Winfred Wang, MD

Blood (2006) 108 (11): 686.

https://doi.org/10.1182/blood.V108.11.686.686

Published: 2006

Journal Articles

Therapeutic Intervention and Decision-Making by Parents of Children with Severe Sickle Cell Anemia.

Jane Hankins, MD, MS, Sara Day, MSN, Yvonne Carroll, RN, Paula Naidu, MPH, Pam Hinds, RN, PhD, Chin-Shang Li, PhD, Winfred Wang, MD

Blood (2005) 106 (11): 3193.

https://doi.org/10.1182/blood.V106.11.3193.3193

Published: 2005

Journal Articles

Therapeutic Intervention and Decision-Making by Primary Caregivers of Children with Severe Sickle Cell Anemia.

Jane Hankins, MD, MS, Sara Day, RN, MSN, Yvonne Carroll, RN, JD, Paula Naidu, MPH, Chin-Shang Li, PhD, Pamela Hinds, RN, PhD, Patricia Garvie, PhD, Winfred Wang, MD

Blood (2004) 104 (11): 1661.

https://doi.org/10.1182/blood.V104.11.1661.1661

Published: 2004

NARROW

Agreement Between R2 and R2* Liver Iron Estimates Is Independent of the Type of Iron Removal Therapy: Results from the Twitch Trial

Hydroxyurea at Maximal Tolerated Dose (MTD) Prior to Completion of the β-Globin Switch Has Additive but Not Sustained Benefits in Fetal Hemoglobin Production

Genetic Predictors of Hydroxyurea Response in Children with Sickle Cell Disease.

Cardiac T2* Magnetic Resonance Imaging (MRI) in Iron Overload and Ventricular Diastolic Function.

Phase I Study of Combination Treatment with Hydroxyurea and Magnesium Pidolate in Children with Sickle Cell Anemia.

Therapeutic Intervention and Decision-Making by Parents of Children with Severe Sickle Cell Anemia.

Therapeutic Intervention and Decision-Making by Primary Caregivers of Children with Severe Sickle Cell Anemia.

Email alerts

ASH Publications

American Society of Hematology

Agreement Between R2 and R2* Liver Iron Estimates Is Independent of the Type of Iron Removal Therapy: Results from the Twitch Trial

Hydroxyurea at Maximal Tolerated Dose (MTD) Prior to Completion of the β-Globin Switch Has Additive but Not Sustained Benefits in Fetal Hemoglobin Production

Genetic Predictors of Hydroxyurea Response in Children with Sickle Cell Disease.

Cardiac T2* Magnetic Resonance Imaging (MRI) in Iron Overload and Ventricular Diastolic Function.

Phase I Study of Combination Treatment with Hydroxyurea and Magnesium Pidolate in Children with Sickle Cell Anemia.

Therapeutic Intervention and Decision-Making by Parents of Children with Severe Sickle Cell Anemia.

Therapeutic Intervention and Decision-Making by Primary Caregivers of Children with Severe Sickle Cell Anemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only